Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Regulation of autophagy | R-HSA-9612973 | 0 | AR-A014418 | 15541 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | AR-A014418 | 15541 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | methanthelinium bromide | 5883 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | methanthelinium bromide | 5883 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | methanthelinium bromide | 5883 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | methanthelinium bromide | 5883 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | methanthelinium bromide | 5883 | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | methanthelinium bromide | 5883 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | methanthelinium bromide | 5883 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | methanthelinium bromide | 5883 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | nicardipine | 4474 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | nicardipine | 4474 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | chloramphenicol | 2153 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | chloramphenicol | 2153 | drug-path |
| Long-term potentiation | R-HSA-9620244 | map04720 | chloramphenicol | 2153 | drug-path |
| Non-homologous end-joining | R-HSA-5693571 | map03450 | chloramphenicol | 2153 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | chloramphenicol | 2153 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | chloramphenicol | 2153 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | chloramphenicol | 2153 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | chloramphenicol | 2153 | drug-path |